Berlin, Berlin, Germany
I sold my first product online at 16 — night vision devices, shipped from my childhood bedroom. It was beautifully profitable until it wasn't. That early collision between entrepreneurial ambition and regulatory reality taught me something I carry to this day: if you're going to build, build all the way in. Half-measures get you in trouble. Two decades later, I'm all the way in. I'm the CEO and founder of aiomics, where we're building the clinical intelligence layer for European hospitals. Our platform captures patient information from every source — referral letters, prior records, lab systems, clinical notes — verifies it for completeness and consistency, and turns it into a single, trusted, structured record from the moment a patient walks through the door. The problem we solve is deceptively simple: clinicians across Europe spend hours every day re-reading, re-entering, and re-writing the same patient information. It's the #1 driver of documentation burden, a major source of medical errors, and it costs health systems billions. We built aiomics to end that cycle. Why me: I practiced medicine in Germany's top-ranked pulmonary clinic and Charité's emergency room after also studying Public Health at LSHTM and Public Policy at Oxford. I've spent the last decade building, advising, and investing in digital health — from co-founding a venture that secured early backing from Roche (via RoX Health) to advising major companies on healthcare M&A and early stage investing. I've led ISO 13485-aligned medical device development, built a corporate digital health venture inside a hospital group of a DAX-listed company, and keynoted on healthcare innovation across Europe for organizations including GlaxoSmithKline, Biogen, and Medtronic. Before all of that, I served as an airborne infantry reserve officer in the German Bundeswehr's Division Spezielle Operationen — leading soldiers under conditions that taught me more about decision-making under pressure than any degree ever could. I'm building aiomics for hospital leaders who are tired of watching their best clinicians drown in paperwork. If that's you — or if you're an investor, partner, or builder who wants to help fix healthcare's most overlooked infrastructure problem — I'd welcome the conversation.
aiomics is the clinical intelligence layer for European hospitals. We solve healthcare's most expensive administrative problem: fragmented, incomplete, and unreliable patient documentation. Our AI platform ingests data from every clinical source, structures it into a verified record, and makes it instantly usable across the entire care team — from admission through discharge. The result: clinicians get hours back. Hospitals reduce documentation errors, accelerate reimbursements, and create audit-ready records automatically. We are live with major hospital groups in Germany, building toward becoming the standard infrastructure for clinical data intelligence in Europe. Key milestones: → Active deployments with multi-site hospital groups and individual clinicians → Platform covers admission, interdisciplinary coordination, discharge, and insurer documentation → Early investment ecosystem including Vorwerk Ventures, Norrsken Evolve, Calm/Storm → Team of physician, physicist, and engineers
Keynoting across Europe on the future of healthcare, clinical AI, and the intersection of medicine and technology. Regular speaker at industry events for pharma, medtech, hospital groups, and innovation conferences. Recent engagements include GlaxoSmithKline, Biogen, Bertelsmann, Roche. Published author on health technology's future (Penguin RandomHouse). Topics: Healthcare AI in practice · Clinical documentation and data intelligence · Physician entrepreneurship · The future of hospital infrastructure · Digital health regulation in Europe Available for keynotes, panels, and moderation — reach out directly.
Advising healthcare executives, investors, and founders on strategy, technology assessment, and market entry for digital health and clinical AI ventures. Engagements range from investment due diligence (VC/PE) and M&A support to hands-on mentorship of early-stage health tech founders and later-stage PE backed growth journeys. I increasingly also act as an innovation board member for major pharma and medtech companies. Earlier advisory and mentorship roles include coaching healthcare innovators through EIT Health's Mentoring & Coaching Network (one of Europe's largest health innovation support programs, 200+ experts) and mentoring AI startups in the Creative Destruction Lab's ESMT DEEP x Tübingen program, focused on sensor AI, regulation, and real-world clinical validation. And I worked with companies such as Audi Business Innovations on their digital health innovation strategy. Focus areas: health technology assessment, clinical AI due diligence, regulatory strategy (EU MDR, ISO 13485), digital health market access, reimbursement, and healthcare data strategy.
Advising on healthcare M&A and digital health partnership mandates in collaboration with the corporate finance advisory Investec Group. I bring clinical and entrepreneurial perspective to deal origination, asset evaluation, and financial structuring across healthcare, life sciences, MedTech, and digital health. This includes identifying acquisition targets, evaluating clinical and commercial viability of health tech assets, and supporting carve-outs, management buy-outs, and capital financing mandates. The role sits at the intersection of everything I've built over the past decade — clinical credibility, regulatory knowledge, and a deep network across European health tech.
Advising one of Europe's most active early-stage venture capital firms on their health tech investment thesis. My role spans deal flow sourcing, clinical and commercial due diligence on potential investments, and strategic sparring with portfolio founders navigating healthcare-specific challenges — from regulatory pathways to hospital sales cycles to clinical validation. I also connect portfolio companies to relevant partners, customers, and domain experts across my network. Working with Speedinvest gives me a systematic view of where European health tech is heading, which directly informs how I think about building aiomics.
Early angel investment in a Vienna-based regulatory technology company simplifying compliance for healthcare and life sciences organisations. I invested based on conviction that regulatory burden is one of the biggest friction points in European health tech — a problem I've experienced firsthand as a medical device founder (Halitus) and in building ISO 13485 quality management systems for our clients back at FoundersLane. Flinn Comply addresses this from the tooling side, and I continue to support the team with domain expertise and introductions where relevant.